TRENDS IN CANADIAN ONCOLOGY HEALTH TECHNOLOGY ASSESSMENT

被引：0
|
作者：
Groff, M. [1 ]
Hwang, S. [1 ]
Daniele, P. [1 ]
Tremblay, G. [1 ]
机构：
[1] Purple Squirrel Econ, Montreal, PQ, Canada
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN177
引用
收藏
页码：S52 / S52
页数：1
相关论文
共 50 条
  • [31] Canadian Regulatory and Health Technology Assessment for Malignant Hematology and Oncology Indications Compared With the US Food and Drug Administration Accelerated Approval Program
    Ho, Cheryl
    Lim, Howard J.
    Regier, Dean A.
    [J]. JAMA NETWORK OPEN, 2021, 4 (08)
  • [32] Integrating Qualitative Research Into Health Technology Assessment in Canada: Experiences of the Canadian Agency for Drugs and Technology in Health (CADTH)
    Moulton, Kristen
    Weeks, Laura
    Berglas, Sarah
    [J]. INTERNATIONAL JOURNAL OF QUALITATIVE METHODS, 2016, 15 (01):
  • [33] Integrative practices of Canadian oncology health professionals
    Brazier, A. S. A.
    Balneaves, L. G.
    Seely, D.
    Stephen, J. E.
    Suryaprakash, N.
    Taylor-Brown, J. W.
    [J]. CURRENT ONCOLOGY, 2008, 15 : S87 - S91
  • [34] 2015 UPDATE OF HEALTH TECHNOLOGY ASSESSMENT DECISIONS ACROSS THE GLOBE: A FOCUS ON ONCOLOGY
    Clark, R. S.
    Campbell, C. M.
    Meyer, K. L.
    Bramley, T. J.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A6 - A6
  • [35] Reviewing and adapting a Local Health Technology Assessment program to departments within a Canadian Health Region
    Austen, L.
    Poulin, P.
    [J]. VALUE IN HEALTH, 2008, 11 (03) : A2 - A2
  • [36] HEALTH TECHNOLOGY ASSESSMENT AND REIMBURSEMENT FOR SELECT ONCOLOGY THERAPIES IN EUROPEAN MAJOR MARKETS
    Koka, N. S.
    Syed, A. A.
    Ahmad, M.
    Patel, K.
    Nair, S.
    Shah, S.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S329 - S329
  • [37] A CONCEPTUAL FRAMEWORK FOR THE APPROACH TO THE EVALUATION OF ONCOLOGY SURVIVAL BENEFIT IN HEALTH TECHNOLOGY ASSESSMENT
    Monnickendam, G.
    Larkin, M.
    Larkin, J.
    Quinn, C.
    [J]. VALUE IN HEALTH, 2020, 23 : S429 - S429
  • [38] HEALTH TECHNOLOGY ASSESSMENT OF ONCOLOGY THERAPIES IN SPAIN AND ITALY: KEY METRICS AND CONSIDERATIONS
    Privolnev, Y.
    Moore, R.
    Sharma, K.
    [J]. VALUE IN HEALTH, 2018, 21 : S180 - S180
  • [39] MAPPING ACCUMULATING EVIDENCE ACROSS MULTIPLE INDICATIONS IN ONCOLOGY HEALTH TECHNOLOGY ASSESSMENT
    Anwer, S.
    Singh, J.
    Bujkiewicz, S.
    Thomas, A.
    Saramago, P.
    Palmer, S.
    Soares, M.
    Dias, S.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S335 - S335
  • [40] IMPLICATIONS OF GENOME-DRIVEN ONCOLOGY ON EVIDENCE REQUIREMENTS FOR HEALTH TECHNOLOGY ASSESSMENT
    Leslie, I
    [J]. VALUE IN HEALTH, 2018, 21 : S88 - S88
12345